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Abstract	
An aneurysm is a localized blood-filled dilatation of an artery whose consequences 
can be deadly. One of its current treatments is endovascular aneurysm repair 
(EVAR), a minimally invasive procedure in which an endoprosthesis, called a stent-
graft, is placed transluminally to prevent wall rupture. 
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Early stent-grafts were custom designed for the patient through the assembling of 
off-the-shelf components by the operating surgeon. However, nowadays, stent-
grafts have become a commercial product. The existing endoprostheses differ in 
several aspects, such as shape design and materials, but they have in common a 
metallic scaffold with a polymeric covering membrane. 
This paper aims to gather relevant information for those who wish to understand 
the principles of stent-grafts and even to develop new devices. Hence, a stent-graft 
classification based on different characteristics is presented, and the significant 
features of an ideal device are pointed out. Additionally, the materials currently in 
use to fabricate this type of prosthesis are reviewed and new materials are 
suggested. 
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Introduction	
An aneurysm, also known as aneurism, is a bulge in a weakened portion of a blood 
vessel wall much like the bulge that results from over-inflating a tube. Generally, 
an aneurysm can be defined as a permanent and irreversible localized dilatation of 
an artery, having at least a 50% increase in diameter compared with the normal 
one [1]. 
Aneurysms occur most commonly in the aorta, as well as in arteries located at the 
base of the brain and in the legs. If left untreated, they may burst or rupture 
causing a hemorrhagic stroke – in the case of brain aneurysms – or, when located 
in the aorta or other abdominal vessels, hipovolemic shock, and even death, due to 
massive blood loss. 
Aortic aneurysms, both thoracic and abdominal (Fig. 1), although relatively 
indolent, are severe diseases. It is estimated that thoracic aortic aneurysms (TAA’s) 
affect 10.4 per 100,000 person-years [2] while abdominal aortic aneurysms (AAA’s) 
affect between 12 to 15 per 100,000 person-years [3]. 
Since the early 1950s, the common treatment of aortic aneurysms has consisted of 
an open surgery and the replacement of the diseased segment of the aorta by a 
synthetic graft [4, 5]. However, as far as AAA’s is concerned, population-based 
studies suggest the mortality rates associated to this procedure are significant with 
mortality rising to 8%, and 10% of patients may present cardiac complications, 
respiratory failure or renal failure [6, 7]. 
In the early 1990s, Volodos (in Ukraine) and Parodi (in Argentina) demonstrated 
that the transluminal placement of a graft within an AAA was a safe and feasible 
procedure that can be a suitable alternative to the open surgery [8]. In 1994, Dake 
confirmed that the procedure was practicable as well in the case of TAA’s [9]. 
Presently, published data shows that the treatment of both abdominal and thoracic 
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aortic aneurysms is also viable with total laparoscopy or assisted laparoscopy [10, 
11]. 
Endovascular aneurysm repair, or EVAR, is a percutaneous minimally invasive 
procedure in which an endoprosthesis, i.e., a stent-graft, is guided from the femoral 
artery to the affected artery segment. The objective of this procedure is to shield 
the aneurysm sac from the blood pressure and, thus, prevent the rupture of the 
artery wall. 
Stent-grafts are one of the key elements in the EVAR’s success. In the first 
applications, the devices were designed individually for the patient but, presently, 
several commercial devices, which have different designs and are made of distinct 
materials, are available. The introduction of such devices increased the availability 
of EVAR, allowing the selection of the appropriate device for each patient and/or 
pathology [12]. Although there are several publications describing the devices 
currently available in the market and the features that stent-grafts should include, 
there is no document that approaches the properties of the materials used. Thus, 
this papers intents to fill this gap. The information gathered here allows an 
enhanced comprehension of stent-grafts as well as establish guidelines for 
improving them. 
This paper is organized as follows. After the introduction, a classification scheme for 
stent-grafts based on different characteristics is proposed. Next, the “ideal” stent-
graft is introduced and described. In the subsequent section, the materials used are 
itemized, and their most relevant features and performances are indicated. 
Additionally, the manufacturing processes are addressed. Finally, a reflection on 
promising materials for stent-grafts is presented. 
Classification	of	stent‐grafts	
A stent-graft is an endoprosthesis classified as a class III medical device both in 
Europe and in the USA. It can be defined as a tubular device composed of a flexible 
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membrane, i.e., a graft, supported by a rigid structure. The skeleton, called the 
stent, acts as an arterial attachment mechanism and provides structural support to 
both the graft and the treated vascular segment. The graft forms a new conduit 
that protects the diseased artery from the pulsatile blood pressure. 
These medical devices have been used in the treatment of aneurysms, aortic 
dissection, trauma and occlusive pathologies. According to the illness and the 
deployment site in which they are applied, their requirements as well as their 
design differ. Table 1 presents a classification based on different characteristics 
such as shape, deployment technique, and fixation method. 
Regardless of the shape, stent-grafts present distinct combinations of proximal and 
distal ends as Fig. 2 illustrates. However, the design of the stent-graft has 
implications for the deployment site and influences the sealing performance and the 
migration resistance. For example, when selecting a stent-graft for an aneurysm 
with a short neck or a tortuous anatomy, the selected device should have a small 
first covered spring because such a design does not compromise the sealing and 
assures full apposition of the device. If the device is to be deployed near a 
peripheral artery, a device whose termination does not interrupt the blood flow, 
e.g., scalloped flares (Fig. 2a) or bare stent (Fig. 2f), is preferable. Currently, in the 
market, one can find fenestrated and branched stent-grafts [13]; these devices are 
suitable to treat aneurysms that involve peripheral arteries in order to maintain the 
blood flow. 
In stent-grafts with sinusoidal stents, the number of apexes influences the sealing: 
the higher the number of apexes, the higher the number of points that press the 
graft onto the artery providing superior sealing. 
“Ideal”	stent‐graft	
The earliest devices used for EVAR were custom designed for each patient, by the 
operating surgeon assembling individual parts. Since then, numerous aortic 
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endografts have been developed worldwide and are now commercially available 
[12, 14]. The design of the devices has remained the same, but some of the early 
problems, such as stent fracture and graft rupture, have been solved by using new 
materials and manufacturing techniques. In addition, improvements occurred in the 
deployment system. Nowadays, it is possible to identify a more or less consensual 
definition of how an ideal stent-graft should perform; some of those features are 
presented below. 
Biocompatibility, i.e., the ability of a material to remain biologically innocuous 
during its functional period inside a living creature [15], is of decisive importance 
since stent-grafts are placed inside the human body in direct contact with blood. 
Hence, the materials chosen, besides being biostable, cannot be toxic, allergic or 
carcinogenic; they also cannot cause thrombosis and hemolysis. It is desirable that 
they promote a thin hyperplasia, but the human body must tolerate them so as not 
to cause a foreign body reaction or an inflammatory reaction. Furthermore, the 
device should be capable of being adequately sterilized and stored as an "off-the-
shelf" product. 
The “ideal” stent-graft should have and maintain the same compliance as a normal 
aorta without interfering with the surrounding anatomical structures. Additionally, 
its design ought to be the least invasive possible and be able to conform to the 
aorta’s anatomy in order to minimize flow resistance and pressure drops. In fact, 
the best stent-graft will be the one that can overcome most of the anatomical 
obstacles, thus achieving success in the largest number of cases. 
Stent-grafts should also mimic the aorta’s mechanical properties. Not only should 
they exceed the patient’s life expectancy, but they also should be flexible so that 
the profile can be maintained without kinking or bending. They should be tough yet 
ductile in order to avoid stent fracture and later complications. Furthermore, to 
withstand the continuous pulsatile blood flow, they should be fatigue resistant, 
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wear resistant and have a stable configuration, i.e., they cannot allow excessive 
elongation, overexpansion or bursting. 
The rate of tissue ingrowth depends on the graft’s porosity [16] and it should be 
such that favors good healing and perfusion without being responsible for 
endoleaks or blood ultrafiltration. 
Fabric erosion occurs because the endograft is a moving prosthesis composed of 
metal stents and soft fabric [17]. To prevent such a problem and consequent 
endoleaks, if new devices are composed by a stent and a graft, fabrics should be 
resistant to wear and tear, especially near the holes made by sewing the stent to 
the graft. Additionally, stents must exhibit excellent corrosion resistance and exhibit 
outstanding surface finish with very low roughness in order to prevent graft 
abrasion [18]. 
Radial force is another crucial feature in the design of a stent-graft. This force is 
important, not only for stents to stay open without being crushed with muscular 
activity, but also to provide a good seal and to ensure a secure fixation. When 
defining this parameter, it is necessary to make a trade-off: the device must be in 
its place without damaging the endothelium cells. In order to minimize stent-graft 
migration, currently, some devices have barbs; however, if the prosthesis fails, 
removing it is almost impossible due to the damages inflicted in the artery wall. 
Radiopacity is an essential trait given that it is necessary to trace the stent-graft 
during the deployment and follow the evolution of the device within the patient's 
arteries. 
Stent-grafts should have a low profile to facilitate the deployment and minimize 
lesions in the access arteries. From the selection point of view, a wide range of 
diameters and lengths is useful and, it is convenient if the materials used have a 
predictable behavior, that is, it is possible to foresee how much the device will 
dilate or shrink. 
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Currently, after an EVAR, patients are regularly submitted to imaging exams to 
evaluate the size of the aneurysm sac and detect complications, such as endoleaks, 
endograft migration and module disconnection. The ideal stent-graft should be 
designed to avoid these expensive, and potentially harmful, exams; a possible 
solution is to include auto-diagnostic capabilities. 
Regarding the device’s manufacture, besides being cost-effective, the processes 
adopted should be environmentally acceptable, in addition to assuring a high and 
consistent quality. 
Some of the features listed above are “yes” or “no” answers, that is, if a material 
does not meet that requirement it is automatically excluded. However, others 
features, like the radial force, are difficult to define because trade-offs have to be 
made. In these cases, by building a house of quality would it is possible to 
determine the relations between the multiple requirements and find the most 
suitable value. 
Current	materials	
Since Parodi´s stent-graft, these devices have not known significant changes 
regarding both the configuration and the materials used. Grafts are mainly made of 
expanded polytetrafluoroethylene (PTFE) or polyester (PET, Dacron). However, the 
graft of the Quantum Lp (Cordis Endovascular, Miami, USA) was an exception since 
it was made of polyurethane foam [19]. The most common material used in stents 
is Nitinol, a nickel titanium alloy. Nevertheless, some devices use 300 series 
stainless steel, and the Powerlink (Endologix, Irvine, USA) uses a cobalt chromium 
alloy (Elgiloy) instead [20]. The attachment of the stents to the grafts can be made 
either using thermal processes or sewing; when the latter technique is used, 
polyester or polypropylene sutures are employed. To enhance, and even ensure, 
radiopacity, some devices have radiopaque markers whose materials currently are 
platinum, platinum-iridium, tantalum and gold. 
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The main characteristics of the materials used nowadays are pointed out bellow. 
Polyethylene	terephthalate	
Polyethylene terephthalate, sometimes written polyethyleneterephthalate or 
poly(ethylene terephthalate), is a thermoplastic of the polyester family whose 
acronym is PET and, when made into fiber, is commercialized under the name 
Dacron. 
PET is the largest volume synthetic fiber produced worldwide due to its low cost, 
convenient processability, and excellent and tailorable performance [21]. In terms 
of biomedical applications, this polymer is the most important of its family because 
of its chemical and physical properties, Table 2. For use in stent-grafts, its primary 
attributes are dimensional stability, durability, resistance to sterilization and 
biodegradation [22]. 
Dacron fabrics can be either knitted or woven. The latter technique involves at least 
two sets of yarns – one warp (longitudinal) and one filling (crosswise) – laced at 
right angles to each other, Fig. 3. The fabric’s characteristics can be varied 
modifying parameters such as the type of weave, thread spacing, linear density and 
twist factors of the warp and filling yarns. In comparison with other structures, 
woven fabrics are dimensionally stable but less extensible and porous. 
Woven fabrics can be manufactured in thin profiles, but they tend to wrinkle easily 
and have limited ability to conform to sinuous tubular shapes [23]. Nonetheless, 
crimping techniques can be used to increase flexibility, distensibility and kink-
resistance [24]. 
Typically, grafts use one of two kinds of weaves: plain weave and twill weave. Plain 
weave fabrics are very resistant but have low flexibility due to each warp contacting 
with each weft reducing yarns mobility. In twill weaves, the weft – or filling yarn – 
passes over one or more warp yarns and then under two or more warp yarns; this 
braid geometry produces reduced contact surface between yarns conferring good 
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resistance and flexibility. Figures 3b and 3c show these types of weaves that were 
observed in graft materials. 
Nowadays, several PET geometry yarns can be found in the market, ranging from 
monofilaments with rectangular cross-section (16x7 μm2 and larger yarn 
dimensions) to thin monofilaments (10-12.5 μm diameter) that result in thinner 
and flatter grafts with increased wear resistance (Fig. 4) [18]. 
As far as knitted fabrics are concerned, they are divided into two basic types: warp-
knit (similar to tricot) and weft-knit (like a hand-knit sweater), Fig. 5. While in the 
first technique the loops made from each warp are formed along the length of the 
fabric, in weft knitting the loops made by each weft thread are formed substantially 
across the width of the fabric. 
Weft-knitted structures are highly extensible although the dimensional stability can 
be compromised if additional yarns are not used to interlock the loops and reduce 
the extension while increasing elastic recovery. Warp-knitted textiles are extremely 
versatile, and can be engineered with a variety of mechanical properties matching 
those of woven structures. 
Like woven fabrics, the flexibility along with the pore size and distribution of knitted 
structures can be controlled, varying the density of the knit. Compared with woven 
grafts, knitted ones are more flexible and radially distensible. A potential limitation 
of knitted materials is the high porosity, which cannot be reduced below a certain 
value determined by the construction but can be overcome by preclotting the grafts 
with gelatin, collagen, and albumin [16]. However, published data shows that, after 
implantation, knitted grafts suffer a higher dilation [25]. 
ePTFE	
Polytetrafluoroethylene (PTFE), Table 2, is a remarkably versatile polymer. It was 
patented in 1937 by DuPont as Teflon; however, it was in the late 1960s that Gore 
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discovered that rapidly stretching PTFE under the right conditions created a strong 
and microporous material, the expanded PTFE (ePTFE). 
As far as medical applications are concerned, the properties of ePTFE make it a 
standard material. This polymer is biocompatible and, due to its chemical structure, 
is highly nonreactive and nontoxic when implanted in biological tissues [26]. Its low 
coefficient of friction (the lowest of all materials) associated with its low surface 
tension are correlated to a high-velocity flow that resists bacterial growth[27] and 
favours a low thrombogenicity and modest tissue ingrowth [23]. ePTFE is 
chemically stable and, so far, no substance has been found to dissolve it. In 
addition, it is impermeable and has a diminished water adsorption capacity in spite 
of its porous structure. This last characteristic provides ePTFE a better modulus 
match than other polymers for many soft biological tissue applications [26]. 
Compared with polyester, PTFE’s surface has less thrombogenesis than that of 
woven polyester. What could be pointed out as an advantage, in fact, is not, at 
least in the case of an aortic aneurysm because, in this situation, a material like 
Dacron would help coagulate the stagnant blood flow in the excluded aneurism sac. 
With regard to the tissue reaction, PTFE is preferable to polyester because, while 
PTFE causes a low-grade tissue reaction, the other more readily induces an 
inflammatory tissue reaction and granulation [28]. As far as dimensional stability is 
concerned, PTFE is preferable to Dacron since data indicates that the latter tends to 
dilate more than PTFE [29]. Despite the several advantages claimed by ePTFE, 
studies regarding abrasion resistance show a much lower resistance of these fabrics 
when compared with PET grafts [18]. 
ePTFE grafts are normally manufactured by an extrusion process. In this technique, 
PTFE is blended with a lubricant to form a paste. Before placing it in the extrusion 
equipment, the paste is crushed, using high pressure, to form a billet. The extruded 
PTFE is then cut into the desired lengths and placed in a low temperature oven to 
dry. Following, the material is stretched enabling the conversion of extruded PTFE 
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to expanded PTFE, which results in a structure with controlled porosity, with a 
node-fibril microstructure in which solid nodes connect through fine fibrils (Fig. 6). 
The ePTFE is next placed into the sintering oven. After this point, secondary 
operations may be performed.  
The majority of ePTFE used in medical applications has an intermodal distance of 
approximately 30 μm, because of the initial success of vascular grafts with this 
microstructure. However, the ability to tailor ePTFE implants during manufacturing 
has not been exploited, even though it is possible to manufacture ePTFE with 
internodal distances ranging from 1 to 100 μm [26]. 
Polyurethane	
Polyurethanes, also known as PUR or, more commonly, as PU, are copolymers that 
compose a family of polymers in which the chain of organic units is joined by 
urethane links. 
Although PUs were originally developed in the 1930s as surface coatings, foams and 
adhesives [24], in the late 1950s, they started to be used in biomedical 
applications, e.g., as a foam breast prosthesis, and, in the 1960s, became a current 
material in catheters and pacemaker lead insulators. Concerning stent-grafts, 
nowadays, only the graft of the Quantum Lp (Cordis Endovascular, Miami, USA), 
which is in phase III of clinical trials for FDA approval, used this material in an open 
lattice matrix of polyurethane foam. 
Polyurethanes are known for their good biocompatibility, high tensile strength, 
superior abrasion resistance and fatigue properties, as well as lubricity, ease of 
handling and processing versatility. Furthermore, for a given application, it is 
possible to adjust the polymer’s properties, altering its chemical composition. 
Current vascular PUs are elastomeric, which means that they have full elastic 
recovery within the stress limits imposed. In one hand, it is advantageous because 
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after deployment, the device remains stressed but, on the other, the permanent 
elastic loading accelerates degradation [23]. 
 
PET, PTFE and PU foam physical properties (adapted from [30]) 
Nitinol	
Nitinol, an acronym for NiTi Naval Ordnance Laboratory, is an alloy composed of 
nickel (Ni) – between 49.5% and 57.5% - and balance titanium (Ti). In biomedical 
applications, the 55-Nitinol (55 weight% Ni) is the most common due to its shape 
memory properties that allow the creation of complex shapes and its ductility at low 
temperatures [31]. 
Superelasticity and the shape memory effect are two of the most prominent 
features of these alloys. Both characteristics derive from a solid-state 
transformation, from martensitic to austenitic, which can be triggered thermally or 
mechanically, and are dependent on the composition and processing history of the 
material [32]. 
Superelastic Nitinol exhibits a hysteretic stress-strain relationship similar to the 
behavior of natural materials. This feature, which usually is regarded as a drawback 
in traditional engineering applications, is useful in the design of stent-grafts 
because it is responsible for a constant force against the organ wall and resistance 
to crushing. Along with the shape memory effect, superelasticity is important 
during the device’s deployment to help the stent-graft acquire its final shape. In 
addition, both properties are crucial to resist kinking or, more suitably, recover 
from crushing [33]. 
Regarding Nitinol’s fatigue resistance, literature indicates lower endurance values 
when compared with those of others metals used as stent structures (e.g., stainless 
steel and Elgiloy). However, this subject is still under research with limited 
information available. While the quasi-static tension and compression properties of 
Nitinol are reasonably well characterized, its fatigue behavior is not. Nitinol strength 
is widely influenced by the mechanical cycling and by the effect of cycling 
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temperature [34]. Furthermore, the non-linear nature of the superelastic phase 
transformation in Nitinol means that conventional fatigue life theory is difficult to 
apply. The volume fraction of martensitic/austenitic phases and its role in the 
fatigue mechanism is still not clearly understood [35]. Many additional factors can 
affect the fatigue behavior of Nitinol alloys, like microstructure, surface quality, 
type of loading, degree of order of the lattices and particles size distributions [36]. 
Nickel is known to be allergenic and toxic; however, Nitinol is biocompatible and, to 
improve its biocompatibility and corrosion resistance; studies are being carried out 
to eliminate Ni from the surface [37]. 
Nitinol is self-passivating, that is, it forms a stable oxide surface layer that protects 
the base material from general corrosion. Literature shows that the titanium-oxide 
layer formed remains essentially unchanged after implantation but samples from 
surrounding tissues from the vascular wall around Nitinol stents has revealed tiny 
deposits of nickel and titanium compounds, which means that corrosion products 
have been formed and certainly have diffused through the passive layer, thus 
reaching surrounding tissues [38]. To prevent this from happening, passivation 
treatments, such as electropolishing or chemical passivation, are needed. These 
techniques contribute to the elimination of many surface irregularities that are the 
starting point for stress fractures or erosive pits and increase the stability of the 
surface by protecting the bulk material from corrosion, thus increasing the device’s 
durability [39]. 
Stainless	steel	
316L stainless steels, commonly used as stents, are austenitic iron-based alloys 
that contain a minimum of 10.5% Cr (chromium), the amount necessary to form a 
passive oxide, and 8 to 15% Nickel to stabilize austenite at room temperature. 
They have excellent formability, which is controlled by the Ni content, and the low 
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carbon content associated with additions of molybdenum, and niobium makes it 
resistant to corrosion, Table 4. 
Like Nitinol, this steel can release some of its compounds into tissues and fluids. To 
prevent this from happening, surface modifications are needed. Among the 
treatments available, the ion implantation technique is one of the commonly used 
to improve wear and corrosion resistance of stents. For example, is proved that N+ 
ion implantation with 1016 ions/cm2 improve the corrosion resistance of stainless 
steel [40]. Another treatment currently used in surface modifications is 
electropolishing, where the wire surface is oxidized by a single of a mixed acidic 
electrolyte [41]. 
Elgiloy	
Elgiloy is a cobalt-nickel-chromium-iron alloy with typical compositions, in wt % 
(weight percent), of 39.0±41.0 Co (cobalt), 19.0±21.0 Cr, 14.0±16.0 Ni, 6.0± 8.0 
Mo (molybdenum), 1.5±2.5 Mn (manganese), 0.10 max. Be (beryllium), 0.15 max. 
C (carbon), and balance of Fe (iron) [42]. It is a high-performance engineering 
material characterized by high strength and ductility as well as good mechanical 
properties, corrosion resistance and excellent fatigue life. As it is biocompatible, it 
is applied in medical applications as surgical implants and instruments, Table 4. 
Elgiloy presents strength and elongation as high as those of stainless steel [43] and 
has superior wear resistance [44]. 
The chromium oxide layer formed by this alloy confers a resistance to corrosion. In 
in vitro studies, nitinol and cobalt alloys may be considered more resistant to 
corrosion than 316L stainless steel when passivated according to ASTM F86 [45]. 
In spite of having good mechanical properties, only two stent grafts made with 
Elgiloy are currently in the market: Powerlink and Lifepath. However, Lifepath is 
only used in Europe. In EUA, clinical trials have been halted due to wireform 
fractures detected and to allow modifications in the device [19]. 
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Furthermore, and in spite of its strong paramagnetism, some authors identified 
relatively large artifacts when magnetic resonance imaging (MRI) was performed 
[42, 46]. This happens because the clusters of magnetic elements, which prevail in 
Co-Cr alloys, cause heterogeneity on the atomic scale of the material [42]. 
Materials:	Future	trends	
Typically, materials for biomedical applications are biocompatible and sterilizable 
and have appropriate mechanical and physical properties. During the selection 
process, the designer seeks materials with good processability for ease of 
manufacturing and tends to neglect cost [47]. However, the increase of human life 
expectancy and the rise of medical expenses will probably change this. The cost will 
then become another variable that will narrow the limited list of materials suitable 
to be used inside the human body. 
Materials	for	stents	
Stent-grafts can be either balloon-expandable or self-expanding. While the formers 
are manufactured in the deliverable configuration, and balloon-dilated to the final 
diameter inside the vessel, self-expanding stent-grafts are manufactured in the 
expanded shape, compressed and constrained in a delivery system, and, upon 
release, spring back to the preset diameter. 
The materials used for balloon-expandable devices (notice that these devices are 
rare) are plastically deformed through the inflation of a balloon and, after the 
balloon is deflated, suffer a slight recoil caused by the elastic portion of the 
deformation. Therefore, the ideal material for these devices should have low yield 
stress, to make it deformable at manageable balloon pressures, and high elastic 
modulus for minimal recoil. In addition to the mechanical behavior, they should 
have enhanced radiopacity, good corrosion resistance and good MRI compatibility. 
Possible materials for these types of stents are tantalum, platinum alloys, niobium 
alloys and cobalt alloys [48-50]. 
17 
During the design of stent-grafts, attention must be given to galvanic corrosion. 
Thus, the use of multiple alloys should be avoided. 
Ultra	high	molecular	weight	polyethylene	
Ultra high molecular weight polyethylene (UHMWPE or UHMW), a subset of the 
thermoplastic polyethylene, is also known as high-modulus polyethylene (HMPE) or 
high-performance polyethylene (HPPE). Its polymerization began in the 1950s and 
one decade later it became the material of choice for total joint arthroplasty in 
orthopedic and spine implants due to its excellent biocompatibility, high impact 
strength and remarkable wear resistance [51], Table 6. During the 1970s, the 
Dutch chemical company DSM started the commercialization of UHMWPE fibers that 
are nowadays widely used in ballistic protection, defense applications, and in 
medical devices. 
Compared with polyester, UHMWPE fibers elicit fewer inflammatory and irritating 
responses while promoting equal or better healing. Furthermore, they offer 
exceptional fatigue resistance and strength allowing the design of lesser invasive 
devices with the same or even higher strength. 
Besides being self-lubricant, UHMWPE has an extremely low coefficient of friction 
and a non-stick surface, which results in very smooth and slippery devices. As the 
fibers are durable, stable, flexible and resistant to abrasion, they represent a good 
choice for moving prosthesis such as stent-grafts. Furthermore, this nonporous 
material has a good chemical resistance and negligible water absorption. 
It is important to notice that all virgin UHMWPE grades are in compliance with US 
Food and Drug Administration regulations and have received US Department of 
Agriculture approval. However, further studies regarding the application of this 
material in grafts are required. 
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Conclusions	
Currently, an ideal stent-graft can be described as being biocompatible, non-toxic 
and non-carcinogenic. It has a stable configuration, and it is flexible, conformable 
and durable. Regarding the mechanical properties, it is resistant to wear, fatigue 
and corrosion. It is ductile and tough and has an optimal porosity. The ideal device 
must also be versatile to successfully address as many anatomies as possible. 
A stent-graft is expected to be compatible with standard angiographic techniques to 
permit its precise deployment and follow-up within the patient's arteries. 
Nonetheless, the ideal device, should also provide information regarding the 
device’s performance to the doctors. 
Commercial stent-grafts are made of two components: a graft, typically made of 
ePTFE or Dacron, and a stent, made of either stainless steel or Nitinol. To improve 
the endoprosthesis performance, new materials and designs are already being 
pursued but there are other materials, such as UHMWPE, that have reveled 
potential to improve the current generation of commercial stent-grafts. 
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FIGURE CAPTIONS 
Fig. 1: Representation of a normal aorta, (A) a thoracic aortic aneurysm located 
behind the heart, and (B) an abdominal aortic aneurysm located below the renal 
arteries. 
Fig. 2: Possible end configurations of stent-grafts, from left to right and from top to 
bottom: (a) scalloped flares, (b) straight cut, (c) bare stent with an extra spring, 
(d) straight open, (e) double stent, (f) bare stent and (g) bare stent with 
protection. 
Fig. 3: Woven fabric: (a) schematic representation; the vertical thread is the “warp 
yarn” direction while the horizontal represents the “weft yarn” or “filling”, (b) SEM 
of an endovascular prosthesis woven fabric with plain weave pattern, (c) SEM of an 
endovascular prosthesis woven fabric with twill weave pattern. 
Fig. 4: SEM of endovascular prosthesis fabric, showing the braid and the geometry 
of the fibers: (a) PET-LP (PET low profile), (b) PET. 
Fig. 5: Knitted fabrics: (a) warp-knit, (b) weft-knit. 
Fig. 6: SEM of ePTFE showing the polymeric node-fibril microstructure. 
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TABLE CAPTIONS 
Table 1: Stent-graft classification. 
Table 2: PET, PTFE and PU foam physical properties (adapted from [30]). 
Table 3: Stainless steel and Elgiloy physical properties (adapted from [30] and 
[52]). 
Table 4: UHMWPE physical properties (adapted from [30]). 
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TABLES 
TABLE 1 
Location Thoracic 
Abdominal 
Peripheral 
Shape Tubular 
Bifurcated 
Fenestrated (only custom-made) 
Diameter Tapered 
Flared 
Non tapered 
Deployment technique Self-expanding 
Balloon inflated 
Release mode Expansion from end to end 
Expansion from middle to end 
Fixation Radial force (without hook or barbs) 
With hooks or barbs 
Pattern of the stent Sinusoidal (wave shape) 
M-shaped 
Diamond 
Multiple rings 
Spiral winding (no commercial device available) 
Methods of graft manufacturing Knitted 
Woven 
Extruded 
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TABLE 2 
Property 
PET  
amorphous 
PTFE 
semi-crystalline 
PU foam 
0.022 specific gravity 
Diameter (µm) 10-50 20.7 - 24.3 -- 
Moment of inertia (m4) 4.91×10-22 
- 
3.07×10-19 
9.01×10-21 
- 
1.71×10-20 
-- 
Density (Kg/m ³) 1290 – 1390 2140 – 2200 2000 – 2400 
Glass transition temperature (ºC) 107 to 125 67.9 to 79.9 -- 
Young’s modulus (Gpa) 2.8 – 3 0.4 – 0.552 7.2 e-5 – 8e-5 
Compressive modulus (Gpa) 2.76 – 4.14 0.402 – 0.423 -- 
Flexural modulus (Gpa) 2.41 – 3.09 0.537 – 0.564 7.2 e-5 – 8e-5 
Yield strength (Gpa) 50 – 55 19.7 – 21.7 0.003 – 0.0035 
Tensile strength (Gpa) 55 – 60 20.7 – 34.5 0.12 – 0.13 
Elongation (% strain) 280 – 320 200 – 400 170 – 180 
Fatigue strength at 10^7 cycles (Mpa) a 19.3 – 29 5.75 – 7 0.084 – 0.091 
Tenacity (N/tex) 0.1 – 0.5 1 - 2 -- 
Breaking tenacity (g/denier) 9.2 1.7 -- 
Friction coefficient 0.39 – 0.44 0.01- 0.05 -- 
Abrasion resistance Very Good Fair -- 
Water absorption at 24 hrs (%) b 0.14 – 0.18 0.005 – 0.01 8 – 10 
Permeability O2 ((cm³.mm)/(m².day.atm)) c 1.2 – 2.77 218 - 363 -- 
Biocompatibility Good Excellent -- 
Price (€/kg) 1.24 -1.36 8.17 – 15.5 7.69 – 12.3 
a Maximum cyclic stress for which the material survives 107 cycles. 
b Weight gain (%) after a sample of test material is immersed in distilled water at room temperature for 
24 hrs. 
32 
c Oxygen permeability is the volume of oxygen that will pass through a unit thickness of material per unit 
area per unit time per unit barometric pressure ((cm³.mm)/(m².day.atm)). 
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TABLE 3 
Property 
Stainless steel 
316L wrought 
Elgiloy 
annealed 
Nitinol [53] 
Ni55Ti45 
   Austenitic Martensitic 
Density (Kg/m ³) 7870 – 8070 8300 6450 
Young’s modulus (GPa) 190 – 205 198 – 211 70-110 21-69 
Yield strength (GPa) 170 – 310 446 – 455 100-800 50 - 300 
Tensile strength (GPa) 480 – 620 808 – 942 800-1500 103 - 1100 
Elongation (% strain) 30 – 50 64.4 – 65.7 1 - 20 up to 60 
Fatigue strength at 107 cycles (MPa) 
256 – 307 428 – 432 
124-190 
[54, 55] 
130-150 
[55] 
Corrosion resistance Good Fair Good to Excellent 
Biocompatibility Good Fair Good 
Price (€/kg) 3.9 – 4.3 14.9 – 16.4 > 100 
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TABLE 5 
Property UHMWPE 
Diameter (µm) 12-21 
Moment of inertia (m4) 1.02×10-21 
- 
9.55×10-21 
Density (Kg/m ³) 931 – 949 
Glass transition temperature (ºC) -130 to -91.2 
Young’s modulus (GPa) 0.894 – 0.963 
Compressive modulus (GPa) 0.894 – 0.963 
Flexural modulus (GPa) 0.894 – 0.963 
Yield strength (GPa) 21.4 -27.6 
Tensile strength (GPa) 38.6 – 48.3 
Elongation (% strain) 350 - 525 
Fatigue strength at 10^7 cycles (MPa) 15.2 – 19.8 
Tenacity (N/tex) 1.5 - 3 
Breaking tenacity (g/denier) 26 - 34 
Friction coefficient 0.04 
Abrasion resistance Excellent 
Water absorption at 24 hrs (%) 0.005 – 0.01 
Biocompatibility Excellent 
Price (€/Kg) 1.99 -2.48 
 
 
 
